{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} ASCO Guidelines Direct Clinical Decisions for Biliary Tract Cancer

Purpose of Activity

To provide information on evidence-based guidelines to assist clinical practice decision making for patients with biliary tract cancer.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Analyze issues regarding biliary tract cancer (BTC) and current treatment recommendations.
  2. Select evidence supporting guidelines by the American Society of Clinical Oncology (ASCO) for treating patients with BTC.
Price: $10.00

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: OT0819
Published: August 2019
Expires: 6/4/2021
Sources: Oncology Times
Passing Score: 7/10 (70%)
Authors: Chuck Holt
Categories: Cancer , Gastrointestinal , Oncology
Specialties: Oncology